Key result
Five patients with ANO5 mutations exhibited wide clinical variability ranging from isolated hyperCKemia to proximo-distal muscular weakness, expanding the genetic spectrum of ANO5-related myopathies.
Why the study?
Biallelic variants in the ANO5 gene cause various muscular disorders, and the study aimed to describe the clinic, histologic, genetic, and imaging features of ANO5-mutated patients.
Case Report (n=5)
Yes
This case series expands the known genetic and phenotypic spectrum of ANO5-related myopathies, highlighting significant clinical variability.
Answers are grounded in this paper and cite their sources.
Supports ANO5 testing in isolated hyperCKemia; extends phenotypic spectrum but leaves open questions on penetrance.
BACKGROUND: Biallelic variants in Anoctamin 5 (ANO5) gene are causative of limb-girdle muscular dystrophy (LGMD) R12 anoctamin5-related, non-dysferlin Miyoshi-like distal myopathy (MMD3), and asymptomatic hyperCKemia. OBJECTIVE: To describe clinic, histologic, genetic and imaging features, of ANO5 mutated patients. METHODS: Five patients, four from France (P1, P2, P3 and P4) and one from Mexico (P5), from four families were included. P1 and P2, belonging to group 1, had normal muscle strength; Group 2, P3, P4 and P5, presented with muscular weakness. Muscle strength was measured by manual muscle testing, Medical Research Council (MRC) grades 1/5 to 5/5. Laboratory exams included serum CK levels, nerve conduction studies (NCS)/needle electromyography (EMG), pulmonary function tests, EKG and cardiac ultrasound. ANO5 molecular screening was performed with different approaches. RESULTS: Group 1 patients showed myalgias with hyperCKemia or isolated hyperCKemia. Group 2 patients presented with limb-girdle or proximo-distal muscular weakness. Serum CK levels ranged from 897 to 5000 UI/L. Muscle biopsy analysis in P4 and P5 showed subsarcolemmal mitochondrial aggregates. Electron microscopy confirmed mitochondrial proliferation and revealed discontinuity of the sarcolemmal membrane. Muscle MRI showed asymmetrical fibro-fatty substitution predominant in the lower limbs.P1 and P2 were compound heterozygous for c.191dupA (p.Asn64Lysfs*15) and c.1898 + G>A; P3 was homozygous for the c.692G>T. (p.Gly231Val); P4 harbored a novel biallelic homozygous exons 1-7 ANO5 gene deletion, and P5 was homozygous for a c.172 C > T (p.(Arg 58 Trp)) ANO5 pathogenic variant. CONCLUSIONS: Our cohort confirms the wide clinical variability and enlarge the genetic spectrum of ANO5-related myopathies.
No takes yet. Share an insight, caveat, or question.
Vázquez et al. (2020) conducted a case report in ANO5-related myopathies (n=5). ANO5 mutations was evaluated on Clinical, histologic, genetic, and imaging features. Five patients with ANO5 mutations exhibited wide clinical variability ranging from isolated hyperCKemia to proximo-distal muscular weakness, expanding the genetic spectrum of ANO5-related myopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: